Catalyst Biosciences Probability of Future Stock Price Finishing Under 0.45

CBIODelisted Stock  USD 7.67  0.83  9.76%   
Catalyst Biosciences' future price is the expected price of Catalyst Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Catalyst Biosciences performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
  
Please specify Catalyst Biosciences' target price for which you would like Catalyst Biosciences odds to be computed.

Catalyst Biosciences Target Price Odds to finish below 0.45

The tendency of Catalyst Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.45  or more in 90 days
 7.67 90 days 0.45 
about 44.14
Based on a normal probability distribution, the odds of Catalyst Biosciences to drop to $ 0.45  or more in 90 days from now is about 44.14 (This Catalyst Biosciences probability density function shows the probability of Catalyst Stock to fall within a particular range of prices over 90 days) . Probability of Catalyst Biosciences price to stay between $ 0.45  and its current price of $7.67 at the end of the 90-day period is about 55.81 .
Given the investment horizon of 90 days the stock has the beta coefficient of 23.38 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Catalyst Biosciences will likely underperform. In addition to that Catalyst Biosciences has an alpha of 20.4432, implying that it can generate a 20.44 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Catalyst Biosciences Price Density   
       Price  

Predictive Modules for Catalyst Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Catalyst Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Catalyst Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
7.677.677.67
Details
Intrinsic
Valuation
LowRealHigh
4.964.968.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Catalyst Biosciences. Your research has to be compared to or analyzed against Catalyst Biosciences' peers to derive any actionable benefits. When done correctly, Catalyst Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Catalyst Biosciences.

Catalyst Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Catalyst Biosciences is not an exception. The market had few large corrections towards the Catalyst Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Catalyst Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Catalyst Biosciences within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
20.44
β
Beta against NYSE Composite23.38
σ
Overall volatility
0.89
Ir
Information ratio 0.13

Catalyst Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Catalyst Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Catalyst Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Catalyst Biosciences is now traded under the symbol GYRE. Please update your portfolios or report it if you believe this is an error. Report It!
Catalyst Biosciences is not yet fully synchronised with the market data
Catalyst Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 794 K. Net Loss for the year was (8.24 M) with loss before overhead, payroll, taxes, and interest of (64.91 M).
Catalyst Biosciences currently holds about 75.39 M in cash with (33.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39.
Roughly 28.0% of the company shares are held by company insiders

Catalyst Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Catalyst Stock often depends not only on the future outlook of the current and potential Catalyst Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catalyst Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding31.5 M
Cash And Short Term Investments21.7 M

Catalyst Biosciences Technical Analysis

Catalyst Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Catalyst Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Catalyst Biosciences. In general, you should focus on analyzing Catalyst Stock price patterns and their correlations with different microeconomic environments and drivers.

Catalyst Biosciences Predictive Forecast Models

Catalyst Biosciences' time-series forecasting models is one of many Catalyst Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Catalyst Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Catalyst Biosciences

Checking the ongoing alerts about Catalyst Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Catalyst Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Catalyst Biosciences is now traded under the symbol GYRE. Please update your portfolios or report it if you believe this is an error. Report It!
Catalyst Biosciences is not yet fully synchronised with the market data
Catalyst Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 794 K. Net Loss for the year was (8.24 M) with loss before overhead, payroll, taxes, and interest of (64.91 M).
Catalyst Biosciences currently holds about 75.39 M in cash with (33.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39.
Roughly 28.0% of the company shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Catalyst Stock

If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing